Labs / Assays & in vitro testing

Brenig Therapeutics
Dover, DE, United States · brenigther.com
Brenig Therapeutics is a biotechnology company developing small-molecule therapies for neurodegenerative diseases, starting with Parkinson’s disease. It is based in Somerville, Massachusetts, and works on clinical-stage programs and AI-enabled drug discovery for CNS disorders.
They take quote requests by email.
What they offer
AI-driven drug discovery platform
Uses a hybrid platform that combines physics-based structural biology with machine learning to design and optimize small molecules.
Small-molecule therapeutic development
Develops brain-penetrant small-molecule medicines for neurodegenerative and neuroinflammatory diseases.
Clinical-stage program development
Advances internally developed programs from discovery into clinical development.
What they work on
- Modalities
- Small molecule, Antibody, Oligonucleotide
- Therapeutic areas
- Parkinson’s disease, neurodegenerative diseases, neuroinflammatory diseases, cardiometabolic diseases
- Sites
- Somerville, United States
- Founded
- 2021
Similar labs. Aurigene Pharmaceutical Services, HitGen, Allumiqs, AxisPharm
Found in a contract services directory. Listing built from brenigther.com. Work here? Claim this listing.